Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Carlos E. de Andrea
Observed names:
Carlos E. De Andrea,
Carlos Eduardo de Andrea
Institutions:
Navarre Institute of Health Research,
Centro de Investigación Biomédica en Red,
Clinica Universidad de Navarra,
Centro de Investigación Biomédica en Red de Cáncer,
Centro de Investigación Médica Aplicada
Observed institutions:
Navarre Institute of Health Research,
Centro de Investigación Biomédica en Red,
Clinica Universidad de Navarra,
Centro de Investigación Biomédica en Red de Cáncer,
Centro de Investigación Médica Aplicada
ORCID:
0000-0002-7628-8050
Observed ORCID:
0000-0002-7628-8050
OpenAlex ID:
A5123205686
Chromosomal instability shapes the tumor microenvironment of esophageal adenocarcinoma via a cGAS–chemokine–myeloid axis
2026
·
Bruno Beernaert
, Rose L. Jady-Clark
, et al.
·
Science Advances
·
14
PDF
Safety and activity of RO7300490, a bispecific CD40 agonist targeted to fibroblast activation protein, in patients with advanced solid tumors: a single-arm, multicenter, first-in-human, phase 1 trial
2026
·
Ignacio Melero
, Bernhard Reis
, et al.
·
Nature Cancer
·
12
PDF
Conventional type-1 DC density is associated with checkpoint inhibitor response across multiple types of cancer
2026
·
Alvaro Lopez-Janeiro
, José González-Gomariz
, et al.
·
Journal of Clinical Investigation
·
5
PDF
Safety, Feasibility, and Pharmacodynamic Activity of Intratumoral Injections of the Agonist Anti-CD137 (4-1BB) mAb Urelumab in Combination with Nivolumab
2026
·
Miguel F. Sanmamed
, Carlos E. de Andrea
, et al.
·
Clinical Cancer Research
·
5
Simultaneous Quantification of Multiple Immune Checkpoint Interactions in Melanoma
2026
·
Cristina Cacho-Navas
, Laura Camacho
, et al.
·
Journal of Clinical Medicine
·
1
PDF
CD70 overexpression at diagnosis predicts relapse and supports dual CD19-CD70 CAR T-cell therapy in follicular lymphoma
2026
·
Ferran Araujo-Ayala
, Maria Ros
, et al.
·
Blood
·
1
Abstract 4121: Incorporation of cut-point robustness in the discovery and evaluation of molecular cancer biomarkers using SCRIBE (Survival Cut-point Reporting and Integrative Biomarker Evaluation)
2026
·
Miguel Lopez de Rodas Gregorio
, Barani Kumar Rajendran
, et al.
·
Cancer Research
·
1
Comprehensive Spatial Methods (CSM): a Toolbox for Spatially Analyzing Tissues in Histopathology
2025
·
Alvaro Lopez-Janeiro
, Eduardo Miraval-Wong
, et al.
·
Laboratory Investigation
·
1
UMITIC: An unsupervised framework for the joint characterization of cellular phenotypes and spatial neighborhoods in multiplex and hyperplex immunofluorescence imaging data
2026
·
María Sangüesa
, Carlos E. De Andrea
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Stromal remodeling and neoantigen clonality as used to evaluate benefit from SIRT–nivolumab in HCC.
2026
·
Josepmaria Argemi
, Sandra Hervas-Stubbs
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
10
Citation count:
40
H-index:
4
I10-index:
2
Year
Topic
Type